menu search

MDNAF / Medicenna: Presenting Data Next Week Plus A Clinical Update Next Quarter

Medicenna: Presenting Data Next Week Plus A Clinical Update Next Quarter
MDNA failed to report data from the fifth dosing cohort, of its phase 1/2 ABILITY study of MDNA11, in Q2'23 as expected. The company is instead presenting data from both the fifth and sixth cohorts of the trial on August 9, 2023. MDNA has cash to last through Q3'24, meaning that is less of a concern right now. However, competitors such as XLO and HOWL are set to produce data in H2'23. Read More
Posted: Aug 1 2023, 15:49
Author Name: Seeking Alpha
Views: 080549

MDNAF News  

Medicenna: Presenting Data Next Week Plus A Clinical Update Next Quarter

By Seeking Alpha
August 1, 2023

Medicenna: Presenting Data Next Week Plus A Clinical Update Next Quarter

MDNA failed to report data from the fifth dosing cohort, of its phase 1/2 ABILITY study of MDNA11, in Q2'23 as expected. The company is instead presen more_horizontal

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

By Seeking Alpha
February 9, 2022

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript more_horizontal

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

By Seeking Alpha
February 9, 2022

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript more_horizontal

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

By Seeking Alpha
February 9, 2022

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q3 2022 Results - Earnings Call Transcript more_horizontal

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
November 12, 2021

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript more_horizontal

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
November 12, 2021

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript more_horizontal

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
November 12, 2021

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q2 2022 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: